162 related articles for article (PubMed ID: 2231603)
1. Potential antimitotic agents. Synthesis of some ethyl benzopyrazin-7-ylcarbamates, ethyl pyrido[3,4-b]pyrazin-7-ylcarbamates, and ethyl pyrido[3,4-e]-as-triazin-7-ylcarbamates.
Temple C; Rener GA
J Med Chem; 1990 Nov; 33(11):3044-50. PubMed ID: 2231603
[TBL] [Abstract][Full Text] [Related]
2. Antimitotic agents. Alterations at the 2,3-positions of ethyl (5-amino-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamates.
Temple C; Rener GA; Comber RN; Waud WR
J Med Chem; 1991 Nov; 34(11):3176-81. PubMed ID: 1956035
[TBL] [Abstract][Full Text] [Related]
3. Antimitotic agents. Chiral isomers of ethyl [5-amino-1,2-dihydro-3-(4-hydroxyphenyl)-2-methylpyrido[3,4-b]pyrazin-7 -yl]carbamate.
Temple C; Rener GA
J Med Chem; 1992 Mar; 35(6):988-93. PubMed ID: 1552512
[TBL] [Abstract][Full Text] [Related]
4. Antimitotic agents: ring analogues and derivatives of ethyl [(S)-5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7- yl]carbamate.
Temple C; Rener GA
J Med Chem; 1992 Dec; 35(26):4809-12. PubMed ID: 1479582
[TBL] [Abstract][Full Text] [Related]
5. Antimitotic agents: structure-activity studies with some pyridine derivatives.
Temple C; Rener GA; Waud WR; Noker PE
J Med Chem; 1992 Oct; 35(20):3686-90. PubMed ID: 1433180
[TBL] [Abstract][Full Text] [Related]
6. Antimitotic agents: synthesis of imidazo[4,5-c]pyridin-6-ylcarbamates and imidazo[4,5-b]pyridin-5-ylcarbamates.
Temple C
J Med Chem; 1990 Feb; 33(2):656-61. PubMed ID: 2299631
[TBL] [Abstract][Full Text] [Related]
7. 1,2-Dihydropyrido[3,4-b]pyrazines: structure-activity relationships.
Temple C; Wheeler GP; Elliott RD; Rose JD; Comber RN; Montgomery JA
J Med Chem; 1983 Jan; 26(1):91-5. PubMed ID: 6827530
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of potential anticancer agents: imidazo[4,5-c]pyridines and imidazo[4,5-b]pyridines.
Temple C; Rose JD; Comber RN; Rener GA
J Med Chem; 1987 Oct; 30(10):1746-51. PubMed ID: 3656351
[TBL] [Abstract][Full Text] [Related]
9. New anticancer agents: synthesis of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines).
Temple C; Wheeler GP; Elliott RD; Rose JD; Kussner CL; Comber RN; Montgomery JA
J Med Chem; 1982 Sep; 25(9):1045-50. PubMed ID: 7131483
[TBL] [Abstract][Full Text] [Related]
10. New anticancer agents: chiral isomers of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazine-7-car bamate .
Temple C; Rener GA
J Med Chem; 1989 Sep; 32(9):2089-92. PubMed ID: 2769680
[TBL] [Abstract][Full Text] [Related]
11. II. Synthesis and biological evaluation of some bioisosteres and congeners of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469).
Hazeldine ST; Polin L; Kushner J; White K; Bouregeois NM; Crantz B; Palomino E; Corbett TH; Horwitz JP
J Med Chem; 2002 Jul; 45(14):3130-7. PubMed ID: 12086498
[TBL] [Abstract][Full Text] [Related]
12. Antitumor amino-substituted pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications.
Rivalle C; Wendling F; Tambourin P; Lhoste JM; Bisagni E; Chermann JC
J Med Chem; 1983 Feb; 26(2):181-5. PubMed ID: 6827534
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of potential anticancer agents. Pyrido[4,3-b][1,4]oxazines and pyrido[4,3-b][1,4]thiazines.
Temple C; Wheeler GP; Comber RN; Elliott RD; Montgomery JA
J Med Chem; 1983 Nov; 26(11):1614-9. PubMed ID: 6631917
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of 1-[[(dialkylamino)alkyl]amino]-4-methyl-5H-pyrido[4,3-b]benzo[e]- and -benzo[g])indoles. A new class of antineoplastic agents.
Nguyen CH; Lhoste JM; Lavelle F; Bissery MC; Bisagni E
J Med Chem; 1990 May; 33(5):1519-28. PubMed ID: 2329575
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and antibacterial properties of pyrido[2,3-b]pyrazine derivatives].
Miyazawa T; Takabatake T; Hasegawa M
Yakugaku Zasshi; 1997 Feb; 117(2):126-32. PubMed ID: 9084228
[TBL] [Abstract][Full Text] [Related]
16. New anticancer agents: alterations of the carbamate group of ethyl (5-amino-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-yl)car bamates.
Temple C; Rener GA; Comber RN
J Med Chem; 1989 Oct; 32(10):2363-7. PubMed ID: 2795608
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of substituted 1,2,3-benzotriazines and pyrido[3,2-d]-1,2,3-triazines as inhibitors of vascular endothelial growth factor receptor-2.
Zhao XW; Liu D; Luan SL; Hu GD; Lv JL; Jing YK; Zhao LX
Bioorg Med Chem; 2013 Dec; 21(24):7807-15. PubMed ID: 24189187
[TBL] [Abstract][Full Text] [Related]
18. 1-Amino-substituted 4-methyl-5H-pyrido[3',4':4,5]pyrrolo[3,2-c]pyridines: a new class of antineoplastic agents.
Nguyen CH; Bisagni E; Pepin O; Pierré A; de Cointet P
J Med Chem; 1987 Sep; 30(9):1642-7. PubMed ID: 3625709
[TBL] [Abstract][Full Text] [Related]
19. Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
Colotta V; Lenzi O; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Traini C; Pedata F; Morizzo E; Moro S
J Med Chem; 2009 Apr; 52(8):2407-19. PubMed ID: 19301821
[TBL] [Abstract][Full Text] [Related]
20. A novel 3-arylethynyl-substituted pyrido[2,3,-b]pyrazine derivatives and pharmacophore model as Wnt2/β-catenin pathway inhibitors in non-small-cell lung cancer cell lines.
Gong YD; Dong MS; Lee SB; Kim N; Bae MS; Kang NS
Bioorg Med Chem; 2011 Sep; 19(18):5639-47. PubMed ID: 21855350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
